TY - JOUR
T1 - From QAAPAPLE 1 to QAAPAPLE 2
T2 - how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)
AU - Stip, Emmanuel
AU - Grignon, Sylvain
AU - Roy, Marc André
AU - Bloom, David
AU - Osman, Ossama
AU - Amiri, Leena
AU - Abdel Aziz, Karim
AU - Javaid, Syed Fahad
AU - Arnone, Danilo
N1 - Funding Information:
E Stip received fees for lecturing, advisory board work, and traveling and MA Roy received fees for lecturing from Janssen-OtsukaCanada, Lunbeck Canada. E Stip, MA Roy, S Grignon, and D Bloom received fees from the AMPQ for the first version of the QAAPAPLE. E Stip and MA Roy received funding from CIHR and FRQS. D Arnone has received travel grants from Jansen-Cilag and Servier and sponsorship from Lundbeck. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed.
Funding Information:
The authors thank the department of psychiatry of University of Montreal for funding the project for QAAPAPLE2 and the CHUM Foundation.
Publisher Copyright:
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020
Y1 - 2020
N2 - Background: In 2011, the authors published an algorithm summarizing practice guidelines related to the use of long-acting antipsychotics (LAIs) called the Québec Algorithme Antipsychotique à Action Prolongée (QAAPAPLE), and proposed that it be revised every 5–10 years to update it according to most recent scientific knowledge. Therefore, a re-evaluation of the algorithm was conducted to determine which recommendations were still relevant and which needed modification. Methods: The authors conducted a two-fold approach: a review of the literature to include new evidence since 2011 (controlled trials, meta-analyses, and practice guidelines); and a participatory component involving electronic surveys, conferences, encounters with opinion leadres, and patients’ representatives. Results: Overall, prescribers tended to make decisions based on personal experience and conversations with colleagues rather than consulting evidence-based guidelines. To test if the algorithm was useful worldwide, it was presented in the United Arab Emirates, where the feedback was in agreement with the algorithm and its limitations. Conclusions: Since its initial publication, the QAAPAPLE algorithm has been updated to guide clinicians on the use of LAIs. The new algorithm has also been assessed outside Canada to test its generalizability worldwide, and indicated its flexibility, efficiency, and user-friendliness in order to guide clinicians on the use of LAIs.
AB - Background: In 2011, the authors published an algorithm summarizing practice guidelines related to the use of long-acting antipsychotics (LAIs) called the Québec Algorithme Antipsychotique à Action Prolongée (QAAPAPLE), and proposed that it be revised every 5–10 years to update it according to most recent scientific knowledge. Therefore, a re-evaluation of the algorithm was conducted to determine which recommendations were still relevant and which needed modification. Methods: The authors conducted a two-fold approach: a review of the literature to include new evidence since 2011 (controlled trials, meta-analyses, and practice guidelines); and a participatory component involving electronic surveys, conferences, encounters with opinion leadres, and patients’ representatives. Results: Overall, prescribers tended to make decisions based on personal experience and conversations with colleagues rather than consulting evidence-based guidelines. To test if the algorithm was useful worldwide, it was presented in the United Arab Emirates, where the feedback was in agreement with the algorithm and its limitations. Conclusions: Since its initial publication, the QAAPAPLE algorithm has been updated to guide clinicians on the use of LAIs. The new algorithm has also been assessed outside Canada to test its generalizability worldwide, and indicated its flexibility, efficiency, and user-friendliness in order to guide clinicians on the use of LAIs.
KW - Antipsychotics
KW - QAAPAPLE
KW - algorithm
KW - long-acting injections
KW - psychosis
UR - http://www.scopus.com/inward/record.url?scp=85092768582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092768582&partnerID=8YFLogxK
U2 - 10.1080/14737175.2020.1826930
DO - 10.1080/14737175.2020.1826930
M3 - Article
C2 - 32962466
AN - SCOPUS:85092768582
SN - 1473-7175
VL - 20
SP - 1325
EP - 1332
JO - Expert Review of Neurotherapeutics
JF - Expert Review of Neurotherapeutics
IS - 12
ER -